Dr. Haanes advises biotechnology companies on best practices for worldwide protection of their intellectual property.  She and her team are focused on formulating innovative long-term legal strategies which integrate seamlessly into her clients' technological and business objectives. She is an experienced counselor, advising on the creation and management of high-value patent portfolios, freedom-to-operate and patentability issues, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments. She represents a diverse body of entities in technology areas such as vaccines, infectious diseases, medical diagnostics, biomarkers, personalized medicine, therapeutic antibodies, therapeutic nucleic acids, genomics, proteomics, and gene therapy.